Public filings / ADMA on Yahoo Finance (opens in a new tab)
ADMA: insider buying, 13F holders, analyst moves
Adma Biologics Inc - US
A summary of public filings about Adma Biologics Inc - US. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
4 of our 100 managers hold ADMA
Combined reported value $116.2M; 1 sold out since Q1 2026.
Holders among our 100 managers: 2 in Q3 2023, 4 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| Rubric Capital | $78.2M | 0.72% | Added |
| Duquesne Family Office | $23.3M | 0.53% | Added |
| Fundsmith | $13.8M | 0.10% | Unchanged |
| Perceptive Advisors | $952K | 0.01% | Trimmed |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.